2 completed. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 2 |
Follow Xigen SA: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of XG-102 in Reduction of Post-cataract Surgery Intraocular Inflammation and Pain XG-102, Placebo - Inflammation, Pain | Phase 3 | Completed | Xigen SA | 309 | 2015-07-01 | 2017-01-24 |
| Efficacy and Safety of XG-102 in Reduction of Post-cataract Surgery Intraocular Inflammation XG-102, Placebo - Inflammation, Pain | Phase 3 | Completed | Xigen SA | 339 | 2014-09-01 | 2017-01-24 |
Cataract (2) · Inflammation (2) · Pain (2)
D-JNKI-1 (2)
United States (2)
Juli Chalifour (1) · Steven M Silverstein, MD (1)